TP53 and lung adenocarcinoma: These findings suggest that the inhibitory effect of SOX6 in lung adenocarcinoma may be related to the inhibition of G1 transition through up‐regulation of p53 and p21CIPI expression and down‐regulation of β‐catenin and cyclin D1 expression.